Kam, Tae-In <br/><br/>
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease.  [electronic resource] 

 -  Science (New York, N.Y.)  11 2018 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-9203 
<br/><br/><label>Standard No.: </label>10.1126/science.aat8407  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzimidazoles--pharmacology<br/>Brain--metabolism<br/>Cell Death<br/>Dopaminergic Neurons--metabolism<br/>Enzyme Activation<br/>Gene Knockout Techniques<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Nitric Oxide--metabolism<br/>Parkinson Disease--metabolism<br/>Poly (ADP-Ribose) Polymerase-1--antagonists & inhibitors<br/>Poly Adenosine Diphosphate Ribose--metabolism<br/>Poly(ADP-ribose) Polymerase Inhibitors--pharmacology<br/>Recombinant Proteins--genetics<br/>alpha-Synuclein--genetics